These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10115053)
41. Evaluating new health information technologies: expanding the frontiers of health care delivery and health promotion. Kreps GL Stud Health Technol Inform; 2002; 80():205-12. PubMed ID: 12026130 [TBL] [Abstract][Full Text] [Related]
42. Prospective value-based assessment of new health care technologies and practices. Girod CS; Axene DV Manag Care; 2000 Aug; 9(8):38-40, 43-7. PubMed ID: 11186514 [No Abstract] [Full Text] [Related]
43. Developing an assessment process for new technologies. Fine A Healthc Financ Manage; 2003 May; 57(5):84-7. PubMed ID: 12772339 [No Abstract] [Full Text] [Related]
44. Who should rightfully decide whether a medical treatment necessarily incurred should be excluded from coverage under a health insurance policy provision which excludes from coverage "experimental" medical treatments? Fisfis BA Spec Law Dig Health Care Law; 1994 Mar; (181):9-32. PubMed ID: 10133063 [No Abstract] [Full Text] [Related]
45. Employer coverage of experimental medical procedures. Mora J Health Cost Manage; 1986; 3(5):17-25. PubMed ID: 10279242 [TBL] [Abstract][Full Text] [Related]
46. The mandate for investigational cancer therapies. Brown E Physician Exec; 1995 Sep; 21(9):46-7. PubMed ID: 10151483 [TBL] [Abstract][Full Text] [Related]
48. Medical technology management: bridging the gap between theory and practice. Shemer J; Abadi-Korek I; Seifan A Isr Med Assoc J; 2005 Apr; 7(4):211-5. PubMed ID: 15847198 [TBL] [Abstract][Full Text] [Related]
49. Commentary--medical technologies: a perspective of the Carter administration. Omenn GS; Ball JR Forum Med; 1980 Jun; 3(6):374-5. PubMed ID: 10247163 [No Abstract] [Full Text] [Related]
50. Managed care in the Organization for Economic Cooperation and Development countries: prospects for quality, effectiveness, and equity. Nolan B Health Care Manag; 1995 Oct; 2(1):125-42. PubMed ID: 10165627 [TBL] [Abstract][Full Text] [Related]
53. A technology anthology. Recent writings and remarks on the state of the state-of-the-art. Health Syst Rev; 1997; 30(2):58, 60, 62. PubMed ID: 10165993 [TBL] [Abstract][Full Text] [Related]
54. Technology assessment and the doctor-patient relationship. Wax AL Va Law Rev; 1996 Nov; 82(8):1641-62. PubMed ID: 16715567 [No Abstract] [Full Text] [Related]
55. A primer on the assessment of medical technologies. Matuszewski KA Pharm Pract Manag Q; 1997 Jan; 16(4):53-65. PubMed ID: 10164160 [TBL] [Abstract][Full Text] [Related]
56. Defining quality health care with outcomes assessment while achieving economic value. Shaw LJ; Miller DD Top Health Inf Manage; 2000 Feb; 20(3):44-54. PubMed ID: 10747434 [TBL] [Abstract][Full Text] [Related]
57. Employer-sponsored health plans and experimental medical treatments: life and death cost/benefit decisions. Mrkonich MJ; Engstrom GA Empl Benefits J; 1994 Jun; 19(2):2-7. PubMed ID: 10171852 [TBL] [Abstract][Full Text] [Related]
59. The importance of subjective values to medical technology assessment and health policy. Diamond GA J Invasive Cardiol; 1993; 5(1):17-22. PubMed ID: 10148297 [No Abstract] [Full Text] [Related]
60. Medical technology index helps hospitals spend money wisely. Data Strateg Benchmarks; 1998 Dec; 2(12):182-4. PubMed ID: 10538487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]